20978 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Cytokines; Lymphokines; Interferons Interferons [IFN]
Infection and treatment of neoplasms with vesicular stomatitis virus
#902Peptides, peptidomimetics and small molecule inhibitors of the Epstein-Barr virus mediated fusion and entry process
#903Methods for Treatment and Prevention of Infection
#904DIARYL UREAS AND COMBINATIONS
#905Hepatitis C virus inhibitors
#906Alpha-MSH therapies for treatment of autoimmune disease
#907SUBSTITUTE PYRROLIDINE DERIVATIVES
#908Triazolyl macrocyclic hepatitis C serine protease inhibitors
#909Pyrrolidine Derivatives
#910Arylalkoxyl hepatitis C virus protease inhibitors
#911Method for screening therapeutic agent for glomerular disorder
#912Pyridazinonyl macrocyclic hepatitis C serine protease inhibitors
#913TETRAZOLYL MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS
#914TETRAZOLYL ACYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS
#915Interferon Beta-Like Molecules
#916Therapeutic compositions and methods useful in modulating protein tyrosine phosphatases
#917METHODS FOR TREATING VIRAL INFECTION USING IL-28 AND IL-29 CYSTEINE MUTANTS
#918Cyclopamine analogs
#919Methods and compositions concerning poxviruses and cancer
#920Treatment of diseases caused by viral infection
#9214-SUBSTITUTED PYRROLIDINE AS ANTI-INFECTIVES
#922Interferon-beta and/or lambda for use in treating rhinovirus infection in the elderly
#923Methods and compositions for delivering active agents with enhanced pharmacological properties
#924Modified human four helical bundle polypeptides and their uses
#925Thiophene analogues for the treatment or prevention of flavivirus infections
#926Cyclopamine analogs
#927OXIMYL DIPEPTIDE HEPATITIS C PROTEASE INHIBITORS
#928Method of treating with interferons
#929AZA-TRIPEPTIDE HEPATITIS C SERINE PROTEASE INHIBITORS
#930PIPERIZINYL MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS
#9312′,3′-dideoxynucleoside analogues for the treatment or prevention of infections
#932ARYLPIPERIDINYL AND ARYLPYRROLIDINYL MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS
#933Compositions and Methods for Treating Burns
#934Combinations Therapy for Treatment of Demyelinating Conditions
#935Combination Preparation of a Biological Response Modifier and an Anticancer Agent and Uses Thereof
#936Albumin Fusion Proteins
#937Albumin Fusion Proteins
#938Albumin Fusion Proteins
#939Albumin fusion proteins
#940Stabilizing alkylglycoside compositions and methods thereof
#941Albumin Fusion Proteins
#942Quinoxalinyl dipeptide hepatitis C virus inhibitors
#943N-FUNCTIONALIZED AMIDES AS HEPATITIS C SERINE PROTEASE INHIBITORS
#944Hcv Ns3-Ns4a Protease Inhibition
#945Cancerous disease modifying antibodies
#946Percutaneously Absorbable Preparation, Percutaneously Absorbable Preparation Holding Sheet, and Percutaneously Absorbable Preparation Holding Equipment
#947Albumin Fusion Proteins
#948Methods and compositions for contributing to the treatment of cancers
#949SMALL PARTICLE LIPOSOME AEROSOLS FOR DELIVERY OF ANTI-CANCER DRUGS
#950PHARMACEUTICAL COMPOSITION COMPRISING A CYTOKINE
#951Use of IL-18BP isoforms for the treatment and/or prevention of neurological inflammatory diseases
#952Therapeutic compositions and methods useful in treating hepatitis
#953Treatment of inflammatory diseases using placental stem cells
#954Microdevice And Method For Transdermal Delivery And Sampling Of Active Substances
#955USE OF OSTEOPONTIN FOR THE TREATMENT AND/OR PREVENTION OF NEUROLOGIC DISEASES
#956Methods for treatment and management of macular degeneration using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione
#957Modified Human Four Helical Bundle Polypeptides and Their Uses
#958β-L-2′-deoxynucleosides for the treatment of resistant HBV strains and combination therapies
#959THERAPEUTICS TO FACILITATE CELL TRANSPLANTATION FOR LIVER DISEASE
#960Treating hepatitis C virus infection
#961Use of IL-28 and IL-29 to treat cancer and autoimmune disorders
#962Modified human four helical bundle polypeptides and their uses
#963TREATMENT OF WOUNDS USING IL-17B
#964Antiviral nucleosides
#965METHODS AND DEVICES FOR ADMINISTRATION OF SUBSTANCES INTO THE INTRADERMAL LAYER OF SKIN FOR SYSTEMIC ABSORPTION
#966Modified Human Four Helical Bundle Polypeptides and Their Uses
#967METHODS AND DEVICES FOR ADMINISTRATION OF SUBSTANCES INTO THE INTRADERMAL LAYER OF SKIN FOR SYSTEMIC ABSORPTION
#968Use of a combination of cyclosporine and pegylated interferon for treating hepatitis C (HCV)
#969METHODS AND DEVICES FOR ADMINISTRATION OF SUBSTANCES INTO THE INTRADERMAL LAYER OF SKIN FOR SYSTEMIC ABSORPTION
#970Cytokine protein family
#971Methods for Treating Cancers Using Polymorphic Forms of 3-(4-Amino-1-Oxo-1,3 Dihydro-Isoindol-2-Yl)-Piperidine-2,6-Dione
#972Albumin fusion proteins
#973COMBINATION THERAPY FOR TREATMENT OF VIRAL INFECTIONS
#974RS7 antibodies
#975Uses of Recombinant Super-Compound Interferons
#976METHODS FOR TREATING VIRAL INFECTION USING IL-28 AND IL-29
#977METHODS AND DEVICES FOR ADMINISTRATION OF SUBSTANCES INTO THE INTRADERMAL LAYER OF SKIN FOR SYSTEMIC ABSORPTION
#978METHODS AND DEVICES FOR ADMINISTRATION OF SUBSTANCES INTO THE INTRADERMAL LAYER OF SKIN FOR SYSTEMIC ABSORPTION
#979Modified Human Interferon Polypeptides and Their Uses
#980Modified Human Interferon Polypeptides and Their Uses
#981Formulations having increased stability during transition from hydrophobic vehicle to hydrophilic medium
#982Modified Human Growth Hormone Polypeptides and Their Uses
#983Modified human interferon polypeptides with at least one non-naturally encoded amino acid and their uses
#984Adjuvant agent for hepatitis C
#985Inhibitors of Hepatitis C Virus
#986Modified Human Growth Hormone Polypeptides and Their Uses
#987Modified Human Growth Hormone Polypeptides and Their Uses
#988Modified human four helical bundle polypeptides and their uses
#989Method of using interferon-like protein ZCYTO20 (IL-28A) or ZCYTO22 (IL-28B) to treat hepatitis C
#990COMBINATION THERAPY METHOD FOR TREATING HEPATITIS C VIRUS INFECTION AND PHARMACEUTICAL COMPOSITIONS FOR USE THEREIN
#991METHODS FOR TREATING VIRAL INFECTION USING IL-28 AND IL-29 CYSTEINE MUTANTS
#992Treatment of neoplasms with viruses
#993Dry compositions
#994Stable liquid interferon formulations
#995Stable liquid interferon-beta formulations
#996METHOD FOR USING CALCIUM-SENSITIVE POTASSIUM CHANNEL AGONIST FOR DELIVERING A MEDICANT TO AN ABNORMAL BRAIN REGION AND/OR A MALIGNANT TUMOR
#997Stable liquid interferon formulations
#998Phosphorus-containing hepatitis C serine protease inhibitors
#999Bone Marrow-Related Cells Associated With Tissue Maintenance And/Or Repair
#1000Placental stem cell populations
#1001Cytokine protein family
#1002Novel Aminopyridine Derivatives Having Aurora a Selective Inhibitory Action
#1003Methods of Treatment Using Interferon-Tau
#1004Combination Therapy for Immunostimulation
#1005Methods, systems and reagents for scar reduction
#1006CARBON-SUBSTITUTED DIKETOPIPERAZINE DELIVERY SYSTEMS
#1007Controlled release compositions for interferon based on PEGT/PBT block copolymers
#1008Stabilizing alkylglycoside compositions and methods thereof
#1009Stabilized interferon liquid formulations
#1010Albumin fusion proteins
#1011Macrocylic oximyl hepatitis C protease inhibitors
#1012Two-piece, internal-channel osmotic delivery system flow modulator
#1013Nucleoside derivatives as inhibitors of rna-dependent RNA viral polymerase
#1014Placental stem cell populations
#1015Pharmaceutical Formulations for the Prolonged Release of Interferons and Their Therapeutic Applications
#1016Cytokine protein family
#1017METHODS FOR TREATING VIRAL INFECTION USING IL-28 AND IL-29
#1018Compositions for and Methods for Treating Hiv
#1019Compositions and methods for targeting metastatic tumors using multivalent ligand-linked carbohydrate polymers
#1020CYTOKINE PROTEIN FAMILY
#1021Hydrogel interferon formulations
#1022Method for treating diseases with omega interferon
#1023Treating Skin Cancer
#1024Respiratory tract delivery of interferon-tau
#1025Antitumor and antiviral combination therapies using low-toxicity, long-circulating human interferon-alpha analogs
#1026TREATMENT OF COUGH WITH INTERFERON
#1027Pharmaceutical compositions containing plasma protein
#1028Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
#1029PARENTERAL LOW DOSE TYPE 1 INTERFERONS FOR BLADDER CANCER
#1030USE OF OSTEOPONTIN FOR THE TREATMENT AND/OR PREVENTION OF NEUROLOGIC DISEASES
#1031Novel HCV inhibitor combinations and methods
#1032Immunoglobulins with Potent and Broad Antiviral Activity
#1033Methods of Using and Compositions Comprising Selective Cytokine Inhibitory Drugs for Treatment and Management of Macular Degeneration
#1034Therapeutic compositions and methods useful in modulating protein tyrosine phosphatases
#1035Method Of Treating Viral Infections
#1036Cancerous disease modifying antibodies
#1037HERBAL COMPOSITIONS, METHODS OF STIMULATING IMMUNOMODULATION AND ENHANCEMENT OF IMMUNOMODULATING AGENTS USING THE HERBAL COMPOSITIONS
#1038Method Of Treatment Using Interferon-Tau
#1039Culturing circular ssDNA viruses for the production of vaccines
#1040METHODS FOR TREATING VIRAL INFECTION USING IL-28 AND IL-29
#1041Methods and pharmaceutical compositions for the treatment and prevention of hepatitis C infection
#1042METHODS FOR TREATING VIRAL INFECTION USING IL-28 AND IL-29
#1043METHODS FOR TREATING VIRAL INFECTION USING IL-28 AND IL-29
#1044Viral hepatitis treatment
#1045ONCOLYTIC VIRUS
#1046PSMA antibody-drug conjugates
#1047Methods and compositions for treatment of viral infections
#1048Nanoparticle compositions of water-soluble drugs for oral administration and preparation methods thereof
#1049CYTOKINE PROTEIN FAMILY
#1050Anti-virus therapy for respiratory diseases
#1051Hmpv treatment with ribavirin and anti-hmpv antibody
#1052Cytokine protein family
#1053Treatment and prevention of liver adverse conditions using gallium
#1054Cytokine protein family
#1055METHODS FOR TREATING VIRAL INFECTION USING IL-28 AND IL-29
#1056CYTOKINE PROTEIN FAMILY
#1057Antineoplastic combinations of temsirolimus and sunitinib malate
#1058Compositions and methods for determining susceptibility of hepatitis C virus to anti-viral drugs
#1059Immunologic compounds for prevention, protection, prophylaxis or treatment of immunological disorders, infections and cancer
#1060Pharmaceutical composition containing interferon for the treatment of hpv infections
#1061Modified 2′ and 3′-nucleoside prodrugs for treating infections
#1062Compounds and compositions for delivering active agents
#1063Interleukin-18 binding proteins, their preparation and use for the treatment of sepsis
#1064Polymer-based delivery system for immunotherapy of cancer
#1065Cream containing interferon encapsulated with liposome
#1066METHOD OF ENHANCING TRANSMUCOSAL DELIVERY OF THERAPEUTIC COMPOUNDS
#1067Antiviral compounds
#1068METHODS FOR TREATING VIRAL INFECTION USING IL-28 AND IL-29
#1069METHODS FOR TREATING VIRAL INFECTION USING IL-28 AND IL-29
#1070METHODS FOR TREATING VIRAL INFECTION USING IL-28 AND IL-29
#1071Method of treating pulmonary disease with interferons
#1072Human serum albumin-free stabilized interferon liquid formulations
#1073IL28 and IL29 TRUNCATED CYSTEINE MUTANTS AND ANTIVIRAL METHODS OF USING SAME
#1074METHODS FOR TREATING VIRAL INFECTION USING IL-28 AND IL-29
#1075METHODS FOR TREATING VIRAL INFECTION USING IL-28 AND IL-29
#1076Method for treatment of demyelinating central nervous system disease
#1077Modified 2′ and 3′-nucleoside prodrugs for treating infections
#1078Modified 2′ and 3′-nucleoside prodrugs for treating infections
#1079Modified 2′ and 3′-nucleoside prodrugs for treating infections
#1080Vaccine immunotherapy for immune suppressed patients
#1081Methods and compositions for treating flaviviruses and pestiviruses
#1082Modified 2' and 3'-nucleoside prodrugs for treating flaviviridae infections
#1083METHODS, COMPOSITIONS AND ARTICLES OF MANUFACTURE FOR CONTRIBUTING TO THE TREATMENT OF CANCERS
#1084Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
#1085Treatment of type 1 immune response-mediated inflammatory lung disease by modulation of ifn-gamma activity
#1086Vaccine immunotherapy for immune suppressed patients
#1087Peroxide removal from drug delivery vehicle
#1088Modified 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections
#1089Modified 2′ and 3′-nucleoside prodrugs for treating infections
#1090Modified 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections
#1091Interferon beta in severe acute respiratory syndrome (sars)
#1092Therapies for renal failure using interferon-beta
#1093HIV-1 mutations selected for by β-2′,3′-didehydro-2′,3′-dideoxy-5-fluorocytidine
#1094Methods for reduction of scar tissue formation
#1095Use of truncated cysteine IL28 and IL29 mutants to treat cancers and autoimmune disorders
#1096METHODS FOR TREATING VIRAL INFECTION USING IL-28 AND IL-29
#1097Low-toxicity, long-circulating human interferon-alpha PEGylated mutants
#1098Compounds, compositions and methods for the treatment of poxvirus infections
#1099Methods related to immunostimulatory nucleic acid-induced interferon
#1100Interferon for treating or preventing a coronaviral infection
#1101Use of alpha-glucosidase inhibitors to treat alphavirus infections
#1102Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
#1103Suspension formulation of interferon
#1104Therapeutic use of tumor necrosis factor-alpha mutein
#1105Use of dronabinol for treatment of side effects of Hepatitis C therapy
#1106Combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection
#1107Materials and methods for inhibition of IgE production
#1108Treatment using an interferon
#1109Methods and compositions for preventing and treating solid tumors
#1110Combined therapy utilizing reduction of DNA methyltransferase expression and/or activity and interferon
#1111Implantable device for continuous delivery of interferon
#1112Extracellular matrix binding chimeric proteins and methods of use thereof
#1113PROCESS FOR NEBULIZING AQUEOUS COMPOSITIONS CONTAINING HIGHLY CONCENTRATED INSULIN
#1114Use of indomethacin and derivatives as broad-spectrum antiviral drugs and corresponding pharmaceutical compositions
#1115Compositions comprising epothilones and their use for the treatment of carcinoid syndrome
#1116Gallium complexes of 3-hydroxy-4-pyrones to treat infection by intracellular prokaryotes and DNA viruses
#1117Pharmaceutical preparation containing palladium complex compounds and the uses thereof for treating cancer and autoimmune disease
#1118Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
#1119Methods for treatment and management of brain cancer using 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-methylisoindoline
#1120Compositions and methods for treating viral infections
#1121Method for inducing an elevated level of adenosine in an individual
#1122Biomarkers for predicting liver fibrosis treatment efficacy
#1123Solvent/polymer solutions as suspension vehicles
#1124Pharmaceutical composition consisting of rapamycine and gastrin 17(LEU15) and a method for treating diabetes
#1125Inhibitors of HCV replication
#1126Methods and compositions for treating flaviviruses and pestiviruses
#1127Compounds and compositions for delivering active agents
#1128Methods of treating disease with glycosylated interferon
#1129Inhibition of SARS coronavirus infection with clinically approved antiviral drugs
#1130IFN receptor 1 binding proteins
#1131Method of treatment using interferon-tau
#1132Vaccine immunotherapy for immune suppressed patients
#11335-nitro-nucleoside compounds for treating viral infections
#1134Dose forms
#1135Fusion polypeptides of human serum albumin and a therapeutically active polypeptide
#1136Enhancement of B cell proliferation by IL-15
#1137Methods and compositions concerning poxviruses and cancer
#1138Medicines including interferon and administering system thereof
#1139Topical skin care composition
#1140Method for providing natural therapeutic agents with high therapeutic index
#1141Combination anti-viral compositions and methods of use
#1142Drug for reducing side effects in ribavirin interferon combination therapy
#1143Modulation of immune function
#1144Interferon beta-like molecules for treatment of stroke
#1145Method of treatment using interferon-tau
#1146Therapeutic agent for hematopoietic tumors
#1147HCV therapy
#1148Cytokine protein family
#1149Combination treatment for multiple sclerosis
#1150Stable pegylated interferon formulation
#1151Organic compounds
#1152Use of treosulfan and derivatives thereof for treating multiple sclerosis
#1153Methods for treatment of chronic uveitis using cyclopropyl-n-{2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-3-oxoisoindoline-4-yl}carboxamide
#1154Method of reducing viral load
#1155Combination preparation of a biological response modifier and an anticancer agent and uses thereof
#1156Method of ameliorating multi-organ failure resulting from ischemic reperfusion injury
#1157Treatments for viral infections using IFN cytokines and ribavirin, alone or in combination
#1158Use of IL-28 and IL-29 to treat cancer and autoimmune disorders
#1159Treatment of diseases caused by viral infection
#1160Interferon compositions and methods of use thereof
#1161Gel composition and methods
#1162Combinations for HCV treatment
#1163Slow release protein polymers
#1164Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
#1165Compositions and methods for treating burns
#1166Thymine nucleosides with anti-hepatitis B virus activity
#1167Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
#1168Substituted prolines as inhibitors of hepatitis C virus NS3 serine protease
#1169Albumin fusion proteins
#1170Albumin fusion proteins
#1171Nanogene therapy for cell proliferation disorders
#1172Formulations having increased stability during transition from hydrophobic vehicle to hydrophilic medium
#1173Method of treating IL-10 deficiency
#1174Immunodynamic complexes and methods for using and preparing such complexes
#1175Recombinant mutants of rhabdovirus and methods of use thereof
#1176Use of vitelline protein B as a microencapsulating additive
#1177Modified vaccinia virus ankara for the vaccination of neonates
#1178(1R,2S,5S)-N-[(1S)-3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3-[(2S)-2-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide as inhibitor of hepatitis C virus NS3/NS4a serine protease
#1179Immunodynamic complexes and methods for using and preparing such complexes
#1180Methods for treating viral infection using IL-28 and IL-29 cysteine mutants
#1181Composition for treatment of and method of monitoring hepatitis C virus using interferon-tau
#1182Enhancement of immune responses
#1183Methods of treatment with interferson and albumin fusion protein
#1184Compositions, systems, and methods for focusing a cell-mediated immune response
#1185Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b
#1186Antitumour compositions containing taxane derivatives
#1187Method of treatment using interferon-tau
#1188Administration of therapeutic viruses
#1189Method of treating idiopathic pulmonary fibrosis with aerosolized IFN-gamma
#1190Modified human interferon polypeptides and their uses
#1191Uses of interferons with altered spatial structure
#1192Method of optimizing treatment with interferon-tau
#1193Method for treating hepatitis C virus with omega interferon
#1194Peptidomimetic protease inhibitors
#1195Combination therapies with L-FMAU for the treatment of hepatitis B virus infection
#1196Biological response modifier for the treatment of cancer
#1197Method for short-term and long-term drug dosimetry
#1198Drug for treating bone disorders
#1199Use of osteopontin for the treatment and/or prevention of neurologic diseases
#1200Combination therapies using vitamin B12 and interferon for treatment of viral proliferative and inflammatory disesases